Bio Pharma Dive
DECEMBER 10, 2023
A new sickle cell disease therapy developed by CRISPR Therapeutics and Vertex Pharmaceuticals is now approved in the U.S. and U.K. This is the story of how it came to be.
Drug Patent Watch
DECEMBER 10, 2023
In the ever-evolving landscape of the biotech and pharmaceutical sectors, accurate valuation of post-revenue drug assets stands as the linchpin for informed and strategic decision-making. The significance of this valuation… The post Decoding Pfizer’s Portfolio: A New Model for Precision in Pharma Investments appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 10, 2023
While new gene therapies for the blood disease grabbed headlines at ASH, Pfizer presented fresh data for an oral drug meant to build on its marketed therapy Oxbryta.
JAMA Internal Medicine
DECEMBER 10, 2023
This cohort study examines the association of periconceptional use of glucagon-like peptide 1 (GLP-1) receptor agonists or other noninsulin second-line antidiabetic medications with increased risk of major congenital malformations.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Pharma
DECEMBER 10, 2023
Roche’s blood cancer portfolio is booming with new life thanks to the antibody-drug conjugate Polivy and bispecifics. | As Roche’s blood cancer portfolio booms with new life thanks to the antibody-drug conjugate Polivy and bispecifics, the company is offering a look at data for two combinations of those drugs that support two phase 3 trials in diffuse large B-cell lymphoma.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Hisamitsu Pharmaceutical here.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Lupin here.
Roots Analysis
DECEMBER 10, 2023
ResMed has sold millions of magnetic CPAP masks since 2014 and received only five reports of serious harm related to the magnets, which were reported to authorities. Introduction to Magnetic CPAP Masks The medical devices domain is facing a wave of safety concerns as ResMed, a prominent manufacturer of continuous positive airway pressure (CPAP) machines, issues an urgent field safety notice regarding its magnetic masks.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Otsuka here.
JAMA Internal Medicine
DECEMBER 10, 2023
This case report describes a patient in their 50s who collapsed, received chest compressions, and recovered consciousness at home.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Cosmo Pharmaceuticals here.
Roots Analysis
DECEMBER 10, 2023
Introduction In the ever-evolving landscape of weight loss solutions, keto gummies and weight loss gummies have emerged as tantalizing options, promising to revolutionize the journey to a healthier, slimmer self. As the hype around these supplements continues to build, the pressing questions on everyone’s minds are: Do they really work, and are they safe?
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Daewoong here.
Roots Analysis
DECEMBER 10, 2023
Introduction In the ever-evolving landscape of medical advancements, a groundbreaking study conducted by Resonant, a Utah-based biotech company specializing in diagnostic tests for neurodegenerative diseases, is developing an Alzheimer’s blood test, a potential game-changer in the early detection of Alzheimer’s disease. The research suggests that a simple blood test could be the key to identifying Alzheimer’s several years before symptoms surface, offering a glimmer of hope for milli
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Almirall here.
Roots Analysis
DECEMBER 10, 2023
Aya Healthcare strengthens its physician recruitment technology by acquiring Winnow AI, a move aimed at boosting its capabilities in the digital staffing sector. In a significant move poised to revolutionize healthcare recruitment, Aya Healthcare, a leading healthcare staffing and workforce solutions provider, has successfully acquired Winnow AI. The acquisition marks a strategic partnership between Aya Healthcare and SwitchPoint Ventures, the creator of Winnow AI, an innovative artificial intel
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for United Laboratories International here.
Roots Analysis
DECEMBER 10, 2023
Novo Nordisk aims to employ insights from obesity drug research to proactively hinder the occurrence of weight gain. Introduction Novo Nordisk, the eminent Danish pharmaceutical giant, has embarked on a groundbreaking journey. While the demand for Novo Nordisk’s weight-loss and diabetes drugs has already propelled the company to the status of Europe’s largest, it now seeks to revolutionize the paradigm by preventing weight gain itself.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Cipla here.
Pharmaceutical Technology
DECEMBER 10, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Sun Pharmaceutical Industries here.
Expert insights. Personalized for you.
357 
Let's personalize your content